Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/03/2010US20100137940 Method for Directed Intranasal Administration of a Composition
06/03/2010US20100137607 Barium salt of benzimidazole derivative
06/03/2010US20100137605 Process for production of piperidine derivatives
06/03/2010US20100137585 Fused heteroaryl derivatives
06/03/2010US20100137584 Fused heteroaryl derivatives
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137566 Compounds and Methods Used to Treat Infectious Diseases
06/03/2010US20100137451 Compositions and methods for treating hoof diseases
06/03/2010US20100137449 Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
06/03/2010US20100137448 Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists
06/03/2010US20100137447 Method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant
06/03/2010US20100137446 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
06/03/2010US20100137444 Ketone compounds and compositions for cholesterol management and related uses
06/03/2010US20100137443 Ibuprofen for Topical Administration
06/03/2010US20100137442 Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
06/03/2010US20100137441 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
06/03/2010US20100137440 Lysine riboswitches, structure-based compound design with lysine riboswitches, and methods and compositions for use of and with lysine riboswitches
06/03/2010US20100137439 Use of aminolevulinic acid and derivatives thereof
06/03/2010US20100137438 Isovaline for treatment of pain
06/03/2010US20100137437 Composition for Inactivating an Enveloped Virus
06/03/2010US20100137436 Bipolar trans carotenoid salts and their uses
06/03/2010US20100137435 Monoacetyldiacylglycerol Derivative for the Treatment of Sepsis
06/03/2010US20100137434 Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
06/03/2010US20100137433 Production of Rosmarinic Acid from Spearmint and uses Thereof
06/03/2010US20100137432 Ophthalmic composition comprising a prostaglandin
06/03/2010US20100137431 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
06/03/2010US20100137430 Treating androgen decline in aging male (adam)-associated conditions with sarms
06/03/2010US20100137429 Composition for transdermal or transmucosal administration
06/03/2010US20100137428 Oxygen containing heterocycles as glycine transporter inhibiting compounds
06/03/2010US20100137427 Softgel of NLKJ for treating prostate diseases
06/03/2010US20100137426 Method for generating reference controls for pharmacogenomic testing
06/03/2010US20100137425 Inhibition and treatment of prostate cancer metastasis
06/03/2010US20100137424 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
06/03/2010US20100137423 Antioxidative composition containing acacia bark derivative
06/03/2010US20100137422 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
06/03/2010US20100137421 Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
06/03/2010US20100137420 Methods and Compositions for Diagnosis and Treatment of Multiple Sclerosis
06/03/2010US20100137419 Anti-cancer agent
06/03/2010US20100137418 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
06/03/2010US20100137417 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
06/03/2010US20100137416 Cadherin-11-mediated modulation of hair growth
06/03/2010US20100137415 Vector for gene therapy
06/03/2010US20100137414 Modulation of Factor 11 Expression
06/03/2010US20100137413 Micrornaome
06/03/2010US20100137412 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
06/03/2010US20100137411 Ras-mediated epigenetic silencing effectors and uses thereof
06/03/2010US20100137410 Oncogenic ALL-1 Fusion Proteins for Targeting Drosha-Mediated MicroRNA Processing
06/03/2010US20100137409 Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
06/03/2010US20100137408 Antisense antibacterial method and compound
06/03/2010US20100137407 Single-chain circular rna and method of producing the same
06/03/2010US20100137406 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/03/2010US20100137405 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/03/2010US20100137403 Method for enhancing cognition or inhibiting cognitive decline
06/03/2010US20100137402 N-[(4,5-diphenyl-2-thienyl)methyl]amine derivatives, their preparation and their therapeutic application
06/03/2010US20100137401 2-methylprop anamides and their use as pharmaceuticals
06/03/2010US20100137400 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
06/03/2010US20100137399 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction
06/03/2010US20100137398 Use of hdac inhibitors for the treatment of gastrointestinal cancers
06/03/2010US20100137397 Chemical Compounds
06/03/2010US20100137396 Treatment of esophageal high grade dysplasia using photodynamic therapy
06/03/2010US20100137395 Process for the Sulfinylation of a Pyrazole Derivative
06/03/2010US20100137394 Pyrazole inhibitors of wnt signaling
06/03/2010US20100137393 Prediction and prophylactic treatment of type 1 diabetes
06/03/2010US20100137392 overactive bladder; oxybutynin and pilocarpine are administered such that the peak saliva flow time point for pilocarpine occurs at nearly the same time as the lowest saliva flow time point for oxybutynin; reduced dry mouth side effect
06/03/2010US20100137391 Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder
06/03/2010US20100137390 1,3-Dihydroimidazole-2-Thione Derivatives as Inhibitors of Dopamine-Beta-Hydroxylase
06/03/2010US20100137389 Topical formulation
06/03/2010US20100137388 Therapeutic Pro-Antibiotic Agents and Methods of Use Thereof
06/03/2010US20100137387 Beta-keto-amide derivatives useful as ion channel modulators
06/03/2010US20100137386 Tnik inhibitor and the use
06/03/2010US20100137384 Anthelmintic Composition
06/03/2010US20100137383 Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents
06/03/2010US20100137382 Therapeutic formulations of desoxyepothilones
06/03/2010US20100137381 Acetamide derivatives as potassium channel modulators
06/03/2010US20100137380 Hypoxic conditioning in patients with exercise limiting conditions
06/03/2010US20100137378 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases
06/03/2010US20100137377 Novel compounds
06/03/2010US20100137371 Novel Pharmaceutical Compounds
06/03/2010US20100137370 Use of 4 cyclopropylmethoxy-n-(3,5 dichloro-1 oxido-pyridin-4 yl)-5-(methoxy)pyridine-2 carboxamide for the treatment of spinal cord traumas
06/03/2010US20100137369 Flowable pharmaceutical depot
06/03/2010US20100137368 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
06/03/2010US20100137367 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
06/03/2010US20100137366 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (ibs)
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137361 Tetrahydro-Quinolinylurea Derivatives
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137358 Solifenacin compositions
06/03/2010US20100137357 Compositions and methods for hyperhidrosis
06/03/2010US20100137356 Azaindole-indole coupled derivatives, preparation methods and uses thereof
06/03/2010US20100137355 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
06/03/2010US20100137354 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
06/03/2010US20100137353 Tricyclic compounds as antibacterials
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100137351 Imidazoacridinone derivative compounds and methods for their use
06/03/2010US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
06/03/2010US20100137349 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
06/03/2010US20100137348 Pharmaceutical formulations: salts of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
1 ... 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 ... 7860